Barclays lowered the firm’s price target on GSK to 1,650 GBp from 1,725 GBp and keeps an Equal Weight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- GlaxoSmithKline (GSK) Reveals Q4 Dividend: Here’s the Essential Information
- GSK says FDA expands Jemperli plus chemotherapy approval to new indication
- GSK price target lowered to 1,850 GBp from 1,950 GBp at Deutsche Bank
- 23andMe CEO Anne Wojcicki Moves to Take Company Private
- UK Stocks: GSK Shares Fall Despite Upgraded Outlook